GLP-1 agonists demonstrate favorable outcomes in promoting weight loss, with patients experiencing a decrease in both body weight and BMI. With this success, it’s also essential to prioritize key aspects of patient care by integrating cardiovascular exercise and muscle-strengthening activities as recommended interventions.
[…]